Major Article - BIT225, in combination with 3-drug antiretroviral therapy, page-203

Research uncovers SARS-CoV-2 viral traits critical for the virus in human airways Oct 26 2020

https://www.news-medical.net/news/20201026/Research-uncovers-SARS-CoV-2-viral-traits-critical-for-the-virus-in-human-airways.aspx

Across the world, scientists are working frantically to develop effective therapies and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.....This discovery suggests that SARS-CoV-2's small envelope (E) glycoprotein has important specific functions in human respiratory cells, as well as in vivo, and further indicates that residues at positions 5 and 6 play key roles in E activities in human cells.

Prior work on SARS-CoV indicates E-mutation variants are attenuated in human cells and in vivo and can be used to construct vaccine strains. The E protein is probably central to viral replication within human respiratory cells, especially these two positions.

Time will tell, but information like this shows promise and BITs' next round of test results aren't that far off (hopefully)